The goal of this clinical trial is to assess if EVD placement using augmented reality is non inferior to image-guidance systems for assistance in adult patients needing an EVD for spontaneous ICH with IVH or severe TBI. The main question it aims to answer is: Can EVDs be placed successfully with at least equal safety and efficacy using augmented reality devices in comparison to using standard image-guidance techniques?
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
50
During EVD placement, an image-guided noninvasive systems will be used to assist the operator for EVD catheter tip navigation through a burr hole opening. The use of image-guidance system occurs once during initial EVD placement in this trial.
During EVD placement, an AR system will be used to assist the operator for EVD catheter tip navigation through a burr hole opening. The use of AR occurs once during initial EVD placement in this trial.
Cooper University Health
Camden, New Jersey, United States
Successful EVD catheter placement
Post-procedural non-contrast head CT will be reviewed by masked assessor to evaluate success of EVD placement per the Kakarla grading system. This grading system classifies catheter positioning into three grades based on postoperative imaging. Grade 1 indicates optimal placement in the ipsilateral frontal horn or third ventricle for effective drainage. Grade 2 represents functional but non-ideal placement in the contralateral ventricle or non-eloquent cortex. Grade 3 denotes suboptimal placement in eloquent cortex or non-target spaces, potentially leading to complications. Thus, a higher score means a worse outcome.
Time frame: During procedure
rate of complication during placement
Time frame: During procedure
rate of catheter tip dispositions
Time frame: During procedure
number of passes for placement
Time frame: During procedure
rate of AR or Stealth overlay failures on first try
Time frame: During procedure
rate of EVD failure
Time frame: from placement to removal of EVD and assessed up to two weeks after
EVD dislodgment of occlusion
Time frame: from placement to removal of EVD and assessed up to two weeks after
rate of EVD replacement or revision
Time frame: During procedure
rate of EVD associated hemorrhage
Time frame: from placement to removal of EVD and assessed up to two weeks after
rate if EVD-associated infection
Time frame: from placement to removal of EVD and assessed up to two weeks after
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.